Pandemic telehealth flexibilities for buprenorphine treatment: A synthesis of evidence and policy implications for expanding opioid use disorder care in the U.S

Noa Krawczyk, Bianca D. Rivera, Carla King, Bridget C.E. Dooling
doi: https://doi.org/10.1101/2023.03.16.23287373

Article Information

doi 
https://doi.org/10.1101/2023.03.16.23287373
History 
  • March 17, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Noa Krawczyk, PhD1,*,
  2. Bianca D. Rivera, MPH1,
  3. Carla King, MPH1 and
  4. Bridget C.E. Dooling, JD2
  1. 1Center for Opioid Epidemiology and Policy (COEP), Department of Population Health, NYU Grossman School of Medicine, New York NY
  2. 2Regulatory Studies Center, The George Washington University, Washington, D.C
  1. ↵*Corresponding Author
    Noa Krawczyk, PhD, Assistant Professor, Center for Opioid Epidemiology and Policy (COEP), Department of Population Health, NYU Grossman School of Medicine, 180 Madison, Room 4-12, New York, NY 10016, Noa.krawczyk{at}nyulangone.org, (914)629-6796
Back to top
Posted March 17, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Pandemic telehealth flexibilities for buprenorphine treatment: A synthesis of evidence and policy implications for expanding opioid use disorder care in the U.S
Noa Krawczyk, Bianca D. Rivera, Carla King, Bridget C.E. Dooling
medRxiv 2023.03.16.23287373; doi: https://doi.org/10.1101/2023.03.16.23287373
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area